Novo Nordisk | driving change to defeat serious chronic diseases

Driving change to avoid plastic waste

ReMed™ is built on the success of our local take back pilot programs, enabling pen users to return their used pens to give the plastic a new life.
Driving change to prevent chronic diseases

We are working in partnership to create a future where fewer people are living with type 2 diabetes and obesity
Working with Diversity & Inclusion

We believe diversity and inclusion help drive our innovation and lead to better and more nuanced decisions.

Driving change towards zero environmental footprint

Investors

Share price

23.02.2024 12:29

851.80 DKK

Go to stock watch -1.40 DKK

Quick links

Novo Nordisk Annual Report

21 February 2024

Notice for the Annual General Meeting of Novo Nordisk A/S

05 February 2024

Novo Nordisk to acquire three fill-finish sites from Novo Holdings A/S in connection with the Catalent, Inc. transaction

31 January 2024

Novo Nordisk files annual report with the SEC

Here are our current job openings. If there is not a job you are looking for, you are welcome to create a job agent or a candidate profile.

We offer 1398 job opportunities